Disorders of pituitary gland, other and/or unspecified

E4_PITUDISNAS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E23.6, E23.7
  • Hospital discharge: ICD-9 253[8-9]
  • Hospital discharge: ICD-8 2539
  • Hospital discharge: excluded ICD-8 25390
  • Cause of death: ICD-10 E23.6, E23.7
  • Cause of death: ICD-9 253[8-9]
  • Cause of death: ICD-8 2539
  • Cause of death: excluded ICD-8 25390

2 out of 7 registries used, show all original rules.

211

4. Check minimum number of events

None

211

5. Include endpoints

None

211

6. Filter based on genotype QC (FinnGen only)

211

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1524 908 598
Only index persons 1235 751 484
Unadjusted period prevalence (%)
Whole population 0.02 0.03 0.02
Only index persons 0.02 0.03 0.02
Median age at first event (years)
Whole population 43.56 42.80 44.54
Only index persons 39.94 38.95 41.48

-FinnGen-

Key figures

All Female Male
Number of individuals 211 130 81
Unadjusted period prevalence (%) 0.04 0.04 0.04
Median age at first event (years) 42.83 40.75 46.15

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
182
Matched controls
1820
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E23.6
ICD-10 Finland
Other disorders of pituitary gland
+∞
98.0
85
*
H02AB09
ATC
hydrocortisone; systemic
209.8
68.3
67
5
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
58.5
53
*
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
50.4
46
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
296.4
46.2
45
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
203.4
46.2
46
*
E23.7
ICD-10 Finland
Disorder of pituitary gland, unspecified
+∞
45.8
42
*
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
+∞
28.9
27
*
102
Kela drug reimbursment
Diabetes insipidus
+∞
27.8
26
*
H03AA01
ATC
levothyroxine sodium; systemic
5.7
24.4
90
267
25398
ICD-8 Finland
Diseases of pituitary gland, Alii definiti
+∞
23.4
22
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
50.2
22.1
26
6
25399
ICD-8 Finland
Diseases of pituitary gland, Other and unspecified
+∞
21.3
20
*
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
+∞
21.3
20
*
E22.1
ICD-10 Finland
Hyperprolactinaemia
+∞
19.1
18
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
11.6
17.6
33
34
N04BC06
ATC
cabergoline; oral (dopamine agonists)
+∞
16.9
16
*
H01AC01
ATC
somatropin; parenteral
+∞
15.9
15
*
E23.2
ICD-10 Finland
Diabetes insipidus
+∞
15.9
15
*
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
+∞
12.6
12
*
G02CB01
ATC
bromocriptine; systemic
19.8
12.3
18
10
301
Kela drug reimbursment
Growth hormone
+∞
11.6
11
*
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
127.7
11.6
12
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
11.6
10.6
19
18
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
116.4
10.5
11
*
E23.05
ICD-10 Finland
Lack of TSH
+∞
10.5
10
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.4
10.5
32
69
XCK00
NOMESCO Finland
Perimetry
5.6
8.4
24
48
2532A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]
+∞
8.4
8
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
8.4
8
*
2538X
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other disorders of the pituitary and other syndromes of diencephalohypophyseal origin[MORBUS HYPOPHYSEOS SEU HYPOTHALAMI ALIA]
+∞
8.4
8
*
25320
ICD-8 Finland
Diseases of pituitary gland, Chromophobe adenoma, pituitary
+∞
8.4
8
*
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
8.4
8
*
E23.03
ICD-10 Finland
Lack of ACTH
+∞
8.4
8
*
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
83.3
7.5
8
*
2539X
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Unspecified
+∞
7.3
7
*
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
+∞
7.3
7
*
22620
ICD-8 Finland
Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)
+∞
7.3
7
*
ZXC86
NOMESCO Finland
Use of endoscopic device
41.6
6.8
8
*
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
+∞
6.3
6
*
D35.30
ICD-10 Finland
Craniopharyngoma
+∞
6.3
6
*
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
+∞
6.3
6
*
E23.06
ICD-10 Finland
Empty sella
+∞
6.3
6
*
E23.08
ICD-10 Finland
Hypopituitarism
+∞
6.3
6
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.7
6.2
26
78
121
Kela drug reimbursment
Severe hypofunction of sexual glands
9.1
6.2
12
14

Mortality – FinRegistry

Association

Association between endpoint E4_PITUDISNAS and mortality.

Females

Parameter HR [95% CI] p-value
E4_PITUDISNAS 2.384 [1.81, 3.14] < 0.001
Birth year 0.992 [0.98, 1.0] 0.063

During the follow-up period (1.1.1998 — 31.12.2019), 84 out of 396 females with E4_PITUDISNAS died.

Males

Parameter HR [95% CI] p-value
E4_PITUDISNAS 1.387 [0.99, 1.95] 0.06
Birth year 0.989 [0.98, 1.0] 0.015

During the follow-up period (1.1.1998 — 31.12.2019), 55 out of 288 males with E4_PITUDISNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_PITUDISNAS.

N-year risk Females Males
1 0.202% 0.217%
5 1.248% 1.664%
10 3.13% 4.363%
15 5.77% 8.112%
20 10.357% 13.946%

Relationships between endpoints

Index endpoint: E4_PITUDISNAS – Disorders of pituitary gland, other and/or unspecified

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data